Diabetic Retinopathy Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Diabetic Retinopathy Market – Report Overview

Pacific Business Consulting’s “Diabetic Retinopathy Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Diabetic Retinopathy market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Diabetic Retinopathy market exceeded a valuation of over US$ 1.4 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 8.0% from 2023 to 2030. The market is expected to potentially surpass US$ 3.0 Billion by 2030.

The prevalence of diabetic retinopathy, a leading cause of blindness in adults with diabetes, is a significant concern globally. Here are key points related to the impact of diabetic retinopathy on blindness and its contribution to market growth:

Prevalence and Impact:

• Diabetic retinopathy is the primary cause of blindness in adults aged 20 to 70 years.
• Up to 21% of type 2 diabetes patients may have diabetic retinopathy at the time of their initial diabetes diagnosis.

Early Detection and Treatment:

• Early detection and treatment of diabetic retinopathy can prevent more than 90% of diabetes-related visual impairment cases.
• According to a CDC analysis, intensive blood glucose management can reduce the risk of diabetic retinopathy by 27%.

Blindness Prevention Measures:

• The rising prevalence of blindness due to diabetes is a major driver for the market.
• Diabetic retinopathy, if left untreated, can progress to sight-threatening stages, leading to blindness and visual impairment.

Global Blindness Statistics:

• According to WHO, diabetic retinopathy contributes to 4.8% of the 37 million blindness cases worldwide.
• The prevalence of diabetic retinopathy is expected to increase rapidly, and it is estimated to affect millions of individuals.

U.S. Statistics:

• In the U.S., an estimated 4.1 million individuals aged 40 years and older have diabetic retinopathy.
• Approximately 899,000 people in this demographic have vision-threatening diabetic retinopathy.

Diabetes-Related Eye Diseases:

• Diabetic persons are at risk for various diabetes-related eye diseases, including cataracts, macular edema, and glaucoma.
• Diabetic retinopathy is projected to increase, with over 11 million people affected by 2030.

Global Diabetic Population:

• The global diabetic population is expected to reach 700 million by 2045.
• An estimated 35 million individuals may become blind due to diabetes, creating a significant public health concern.

Market Growth Drivers:

• Increasing prevalence of diabetes, a growing geriatric population, and rising awareness about diabetes management contribute to market growth.
• New product launches in the diabetic care sector further propel the market.

Global Health Concern:

• Diabetes is a serious global health problem, with diabetic retinopathy resulting from damage to blood vessels in the retina.

In summary, the rising prevalence of diabetes and diabetic retinopathy, coupled with efforts for early detection and treatment, underscores the importance of addressing this public health challenge. The market growth is driven by the urgent need to manage and prevent diabetic retinopathy, a leading cause of vision impairment and blindness.

Leading players in the Diabetic Retinopathy segment, including Ampio Pharmaceuticals Inc., BCNPeptides, Kowa Company Ltd., Genentech, Inc., Bayer AG, ABBVIE INC., Novartis AG, Oxurion NV, Sirnaomics, Alimera Sciences, are expected to play a crucial role in shaping the future landscape of Diabetic Retinopathy technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Diabetic Retinopathy market. It also delves into the analysis of present and prospective market competition within the global Diabetic Retinopathy market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Diabetic Retinopathy market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Diabetic Retinopathy market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Diabetic Retinopathy
   • Global Market Outlook: Diabetic Retinopathy
2. Competitive Intelligence Analysis: Diabetic Retinopathy
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Diabetic Retinopathy
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Diabetic Retinopathy
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Diabetic Retinopathy: Ten Major Market (10MM) – Market Analysis, By Type
   • Proliferative Diabetic Retinopathy
   • Non-proliferative Diabetic Retinopathy
9. Diabetic Retinopathy: Ten Major Market (10MM) – Market Analysis, By Management
   • Anti-VEGF
   • Laser Surgery
   • Vitrectomy
   • Intraocular Steroid Injection
10. Diabetic Retinopathy: Ten Major Market (10MM) – Market Analysis, By End User
    • Hospitals
    • Specialty Clinics
    • Other End Users
11. Diabetic Retinopathy: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

12. S. Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

13. K. Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

14. Germany Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

15. France Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

16. Italy Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

17. Spain Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

18. Japan Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

19. China Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

20. Australia Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

21. India Diabetic Retinopathy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Type
      • By Management
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Type
      • By Management
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer